Was he always not going to be leaving once Ms Angus was appointed , personally i dont necessarily see it as a big deal. Like most bios this will be feast or famine one way or another , im not sure these non exec board changes have too much pull on whether the drug works or not ? If it does then the SP will be many multiples of here , if it doesnt then its probably worth the cash on the balance sheet
Was he always not going to be leaving once Ms Angus was...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
